I have asked Flatiron to adjust the cycle length of their NCCN regimens to coincide with how an oral drug is supplied. For example, osimertinib comes in a 30 day supply yet Flatiron builds a 28 day cycle length. The physicians often end up ordering a 28 day supply and we have to go back and forth to get a 30 day supply on the prescription.

As we all know, audits are frequent and dispensing more qty that the Rx is written for can result in a claw back of many thousands of dollars.

Every package insert provides the qty. per bottle and this could be used when the regimen is being built.  If you agree this this could become an audit issue, please send a request to Flatiron asking if cycle length for oral drugs could be built to reflect the drug bottle size  in the NCCN regimens.

thanks Linda Frisk, PharmD.